top of page

Topic

Molecular Testing

7 Podcasts • 1 Course on BackTable

Molecular Diagnostics for Thyroid Nodules
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable ENT & Allergy

Episode # 277  •  09 Jun 2026

Molecular Diagnostics for Thyroid Nodules

For years, an indeterminate thyroid biopsy has meant diagnostic surgery, but molecular testing is now changing that reality entirely. On this episode of the BackTable ENT & Allergy podcast, Dr. Ashley Agan interviews endocrinologist Dr. Erik Alexander about how molecular testing and a systematic, layered approach to thyroid nodule evaluation are reducing diagnostic surgeries and enabling more individualized patient care.

This podcast is supported by

Veracyte

More on Molecular Testing

Loading recent podcasts…

ENT

ENT & Allergy # 277

Jun 8, 2026

with Dr. Erik Alexander, Dr. Ashley Agan

Molecular Diagnostics for Thyroid Nodules

For years, an indeterminate thyroid biopsy has meant diagnostic surgery, but molecular testing is now changing that...

1,200+ listens

ENT

ENT & Allergy # 274

May 18, 2026

with Dr. Wen Jiang, Dr. Jeff Hyzer, Dr. Gopi Shah

Pediatric Thyroid Nodules: Clinical Insights & Approaches

Pediatric thyroid nodules are rare, but their risk of malignancy is significantly higher than in adults, raising the...

Tumor Board

Tumor Board # 36

Nov 17, 2025

with Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy

Lung Cancer Staging & Systemic Therapies: Recent Advancements

How do leading oncologists interpret the abundance of molecular tests, genomic data, and biomarkers to create a lung...

ENT

ENT & Allergy # 35

Nov 1, 2021

with Dr. David Goldenberg, Dr. Ashley Agan, Dr. Gopi Shah

Thyroid Nodules

Dr. David Goldenberg talks with us about the management of thyroid nodules, including workup, imaging and patient...

2,800+ listens

Tumor Board

Tumor Board # 60

May 18, 2026

with Dr. Neeraj Agarwal, Dr. Arun Azad, Dr. Alan Tan

PARP Inhibitors: Clinical Trials & Real-World Applications

Keeping patients on PARP inhibitors long enough to see real benefit often comes down to proactive side effect...

VI

Vascular & IR # 595

Dec 4, 2025

with Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy

Lung Cancer Staging & Systemic Therapies: Recent Advancements

How do leading oncologists interpret the abundance of molecular tests, genomic data, and biomarkers to create a lung...

1,300+ listens

Curbsiders

Curbsiders # 438

May 5, 2024

with Dr. Harika Gorti, Dr. Sneha Neurgaonkar, Dr. Monee Amin, Dr. Caroline Coleman, Dr. Meredith Trubitt

Recap from SHM #Converge24

We went to it so you don’t have to!...

Multidisciplinary Approach to Non-Small Cell Lung Cancer

Tumor Board Course

2 CME/CE credits, 2.5 hours, 19 lessons

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page